Immuneering (IMRX) Preferred Shares Issued (2020)

Immuneering (IMRX) recorded quarterly Preferred Shares Issued of $37.2 million in Q4 2020.

Immuneering (IMRX) Preferred Shares Issued (2020) Analysis & Trends

Immuneering's Preferred Shares Issued history runs 1 years deep, the most recent figure standing at $37.2 million for Q4 2020.

In Q4 2020, Preferred Shares Issued changed N/A year-over-year to $37.2 million; the TTM figure through Dec 2021 stood at $37.2 million (changed N/A YoY), while the FY2021 annual figure was $24.8 million, up 2383.09% from the prior year.
Preferred Shares Issued was $37.2 million for Q4 2020 at Immuneering.
In the past five years, Preferred Shares Issued ranged from a high of $37.2 million in Q4 2020 to a low of $37.2 million in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	-
9	Abivax	91.71 Bn	91.71 Bn	-	-
10	Immuneering	255.40 Mn	255.40 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	37.20 Mn
Dec 31, 2020	37.20 Mn